N-Acetylcysteine Protection Against Radiation Induced Cellular Damage

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 181 participants.

Also called NCT04154982

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 181 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04154982
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04154982. Randomized; single masking; primary purpose treatment. Start 2020-09-02 (actual); primary completion 2024-12-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
N-Acetylcysteine Protection Against Radiation Induced Cellular Damage
Acronym
CARAPACE
Condition
Cardiac Arrhythmia
Intervention (Drug)
Acetyl cysteine
Lead sponsor
Centro Cardiologico Monzino (class: other)
Collaborator
Ministry of Health, Italy (class: other government)

Record details

Record id
cardio:ct-nct04154982
Content hash
3ce37e3fc9955cedf806c682e24199ea1a8186d5a01c66e86ea829c17c0dbfb5